NIP
GBT

Nicholas Investment Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Nicholas Investment Partners’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-189,392
Closed -$10.4M – 192
2020
Q3 		$10.4M Buy
189,392
+152,293
+411% +$9.68M 1.13% 31
2020
Q2 		$2.34M Sell
37,099
-39,497
-52% -$2.71M 0.48% 81
2020
Q1 		$3.91M Buy
76,596
+9,281
+14% +$622K 0.76% 44
2019
Q4 		$5.35M Sell
67,315
-27,048
-29% -$1.6M 0.55% 51
2019
Q3 		$4.58M Buy
94,363
+5,885
+7% +$307K 0.39% 98
2019
Q2 		$4.65M Buy
88,478
+19,090
+28% +$1.1M 0.43% 80
2019
Q1 		$3.67M Buy
69,388
+59,581
+608% +$2.93M 0.33% 104
2018
Q4 		$403K Sell
9,807
-95,316
-91% -$3.57M 0.04% 209
2018
Q3 		$4M Sell
105,123
-1,149
-1% -$50.9K 0.32% 121
2018
Q2 		$4.8M Buy
106,272
+58,994
+125% +$2.69M 0.34% 91
2018
Q1 		$2.28M Sell
47,278
-6,895
-13% -$385K 0.16% 179
2017
Q4 		$2.13M Buy
+54,173
New +$2.02M 0.14% 203
2017
Q2 		– Sell
-23,142
Closed -$852K – 285
2017
Q1 		$852K Buy
+23,142
New +$583K 0.06% 243

Other funds holding GBT

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nicholas Investment Partners's GBT Position: Q4 2020 in Review

Nicholas Investment Partners sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2020, closing a stake of 189,392 shares — an estimated $10.4M sold.

Nicholas Investment Partners first reported a position in GBT in Q1 2017 and held it in 13 quarters. The position peaked at $10.4M in Q3 2020. 228 funds tracked by Wall St. Rank hold GBT as of Q4 2020.

  • Nicholas Investment Partners reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Nicholas Investment Partners sold 189,392 Global Blood Therapeutics, Inc. shares in Q4 2020, an estimated $10.4M.
  • Nicholas Investment Partners first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 13 quarters.
  • Nicholas Investment Partners's Global Blood Therapeutics, Inc. position peaked at $10.4M in Q3 2020.
  • 228 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2020.

Based on Nicholas Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.